Recent Advances in GPCR-Regulated Leukocyte Responses during Acute Cardiac Injury

Tapas K Nayak1, Douglas G Tilley1

  • 1Center for Translational Medicine, Lewis Katz School of Medicine, Temple University, Philadelphia, PA, United States.

Insights

Leukocyte G protein-coupled receptors (GPCRs) beyond chemokine receptors are key to modulating cardiac repair after myocardial infarction (MI). Targeting these GPCRs offers therapeutic potential for improving heart function post-injury.

Area of Science:

  • Cardiovascular Biology
  • Immunology
  • Molecular Medicine

Background:

  • Leukocyte recruitment after cardiac injury, like myocardial infarction (MI), critically influences heart repair and survival.
  • While chemokine receptors are known regulators, other G protein-coupled receptors (GPCRs) on leukocytes also impact cardiac injury response.
  • Effective modulation of leukocyte activity to promote healing and reduce inflammation post-MI requires further understanding.

Purpose of the Study:

  • To review the role of leukocyte chemokine receptors in cardiac injury.
  • To highlight recent advancements in understanding non-chemokine GPCRs on leukocytes after acute cardiac injury.
  • To explore the therapeutic potential of targeting these GPCRs for cardiac repair.

Main Methods:

  • Literature review focusing on leukocyte behavior and GPCRs in cardiac injury.
  • Analysis of existing research on chemokine receptors and other GPCRs in the context of myocardial infarction.
  • Synthesis of recent findings on GPCRs' impact on leukocyte responses and cardiac outcomes.

Main Results:

  • Chemokine receptors orchestrate leukocyte migration and activation following cardiac damage.
  • Additional GPCRs expressed by leukocytes significantly influence their response to cardiac injury.
  • These non-chemokine GPCRs represent novel therapeutic targets for modulating inflammation and promoting cardiac repair.

Conclusions:

  • Understanding leukocyte GPCRs is crucial for developing strategies to improve cardiac healing post-MI.
  • Targeting specific GPCRs beyond chemokine receptors may offer new avenues for treating heart damage.
  • Further research into GPCR modulation holds promise for enhancing cardiac function and survival after injury.